Back
Compare AU
Compare HLTH vs. R3AL
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck Global Healthcare Leaders ETF (HLTH) and the Clearbridge Real Income Fund - Active ETF (R3AL). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
HLTH | R3AL | |
|---|---|---|
Popularity | Low | N/A |
Pearlers invested | 57 | 0 |
Median incremental investment | $547.55 | $0 |
Median investment frequency | Monthly | N/A |
Median total investment | $1,430.96 | $0 |
Average age group | > 35 | N/A |
Key Summary
HLTH | R3AL | |
|---|---|---|
Strategy | HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars. | R3AL.AX was created on 2010-11-17 by Martin Currie. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide a pre-tax income yield above the S&P/ASX 200 Index yield and to grow this income above the rate of Inflation. |
Top 3 holdings | Illumina Inc (3.14 %) Arrowhead Pharmaceuticals Inc (2.94 %) West Pharmaceutical Services Inc (2.93 %) | Scentre Group (7.51 %) Aurizon Holdings Ltd (7.26 %) Chorus Ltd (6.49 %) |
Top 3 industries | Health Care (100.00 %) Other (9.10 %) | Real Estate (61.04 %) Industrials (20.02 %) Utilities (10.96 %) |
Top 3 countries | United States (65.74 %) Japan (10.95 %) Denmark (8.04 %) | Australia (70.99 %) New Zealand (10.25 %) United States (7.21 %) |
Management fee | 0.45 % | 0 % |
Key Summary
HLTH | R3AL | |
|---|---|---|
Issuer | VanEck | Martin Currie |
Tracking index | MarketGrader Developed Markets ex-Australia Health Care Index - AUD | S&P ASX 200 |
Asset class | ETF | ETF |
Management fee | 0.45 % | 0 % |
Price | $11.53 | $1.54 |
Size | $52.251 million | $456.251 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 0.57 % | 4.60 % |
Market | ASX | ASX |
First listed date | 09/09/2020 | 27/01/2025 |
Purchase fee | $6.50 | $6.50 |
Community Stats
HLTH | R3AL | |
|---|---|---|
Popularity | Low | N/A |
Pearlers invested | 57 | 0 |
Median incremental investment | $547.55 | $0 |
Median investment frequency | Monthly | N/A |
Median total investment | $1,430.96 | $0 |
Average age group | > 35 | N/A |
Pros and Cons
HLTH | R3AL | |
|---|---|---|
Pros |
|
|
Cons |
|
|
HLTH | R3AL |
|---|---|
Lower exposure to AU market | Higher exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Lower distribution yield | Higher distribution yield |